329 related articles for article (PubMed ID: 28586780)
41. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
42. Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer.
Daneshmand S
Curr Opin Urol; 2020 Mar; 30(2):234. PubMed ID: 31922969
[No Abstract] [Full Text] [Related]
43. The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.
Liu Q; Lian Q; Lv H; Zhang X; Zhou F
Mol Diagn Ther; 2021 May; 25(3):273-281. PubMed ID: 33886084
[TBL] [Abstract][Full Text] [Related]
44. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
45. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
[TBL] [Abstract][Full Text] [Related]
46. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
Murray MJ; Nicholson JC; Coleman N
Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
[TBL] [Abstract][Full Text] [Related]
47. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?
Spiekermann M; Dieckmann KP; Balks T; Bullerdiek J; Belge G
Anticancer Res; 2015 Jan; 35(1):117-21. PubMed ID: 25550541
[TBL] [Abstract][Full Text] [Related]
48. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
[TBL] [Abstract][Full Text] [Related]
49. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.
Piao J; Lafin JT; Scarpini CG; Nuño MM; Syring I; Dieckmann KP; Belge G; Ellinger J; Amatruda JF; Bagrodia A; Coleman N; Krailo MD; Frazier AL; Murray MJ
Clin Genitourin Cancer; 2021 Dec; 19(6):469-479. PubMed ID: 34629299
[TBL] [Abstract][Full Text] [Related]
50. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP
Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
52. Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.
Nappi L; Thi M; Lum A; Huntsman D; Eigl BJ; Martin C; O'Neil B; Maughan BL; Chi K; So A; Black PC; Gleave M; Wyatt AW; Lavoie JM; Khalaf D; Bell R; Daneshmand S; Hamilton RJ; Leao RRN; Nichols C; Kollmannsberger C
J Clin Oncol; 2019 Nov; 37(33):3090-3098. PubMed ID: 31553692
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.
Pelloni M; Coltrinari G; Paoli D; Pallotti F; Lombardo F; Lenzi A; Gandini L
Endocrine; 2017 Sep; 57(3):518-527. PubMed ID: 27796811
[TBL] [Abstract][Full Text] [Related]
54. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor.
Belge G; Hennig F; Dumlupinar C; Grobelny F; Junker K; Radtke A; Dieckmann KP
Oncotarget; 2020 Apr; 11(16):1462-1473. PubMed ID: 32363003
[No Abstract] [Full Text] [Related]
55. Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors.
Fern LA; Greenwood M; Smith S; Brand S; Coleman N; Stark DP; Murray MJ
Clin Genitourin Cancer; 2021 Oct; 19(5):381-387. PubMed ID: 33846102
[TBL] [Abstract][Full Text] [Related]
56. Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?
Henrique R; Jerónimo C
Eur Urol; 2017 Feb; 71(2):221-222. PubMed ID: 27543167
[No Abstract] [Full Text] [Related]
57. Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
Ye F; Feldman DR; Valentino A; So R; Bromberg M; Khan S; Funt SA; Sheinfeld J; Solit DB; Pessin MS; Peerschke EI
J Mol Diagn; 2022 Aug; 24(8):867-877. PubMed ID: 35934321
[TBL] [Abstract][Full Text] [Related]
58. miRNA-302s may act as oncogenes in human testicular germ cell tumours.
Das MK; Evensen HSF; Furu K; Haugen TB
Sci Rep; 2019 Jun; 9(1):9189. PubMed ID: 31235829
[TBL] [Abstract][Full Text] [Related]
59. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
60. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]